Eurofins CDMO Alphora is pleased to announce its participation in an international consortium advancing next-generation antibody-drug conjugate (ADC) expression technology. Supported by the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP), the Canadian division is collaborating with Daresbury Proteins Ltd. (UK) to develop a novel, high-yield platform integrating affinity peptide tags directly into monoclonal antibody production. This innovative approach aims to streamline ADC manufacturing, reduce costs, and accelerate development timelines by eliminating traditional processing steps. The project underscores Eurofins CDMO Alphora’s commitment to innovation, strengthening Canada’s role in precision biologics. To read the press release, please visit: EurofinsCDMOConsortium.